Bortezomib, melphalan, and prednisolone combination chemotherapy for newly diagnosed light chain (AL) amyloidosis.
about
Phase 1 study of bortezomib in combination with melphalan and dexamethasone in Japanese patients with relapsed AL amyloidosis.Recurrent mutations of MAPK pathway genes in multiple myeloma but not in amyloid light-chain amyloidosis.Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment.
P2860
Bortezomib, melphalan, and prednisolone combination chemotherapy for newly diagnosed light chain (AL) amyloidosis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Bortezomib, melphalan, and pre ...... light chain (AL) amyloidosis.
@ast
Bortezomib, melphalan, and pre ...... light chain (AL) amyloidosis.
@en
type
label
Bortezomib, melphalan, and pre ...... light chain (AL) amyloidosis.
@ast
Bortezomib, melphalan, and pre ...... light chain (AL) amyloidosis.
@en
prefLabel
Bortezomib, melphalan, and pre ...... light chain (AL) amyloidosis.
@ast
Bortezomib, melphalan, and pre ...... light chain (AL) amyloidosis.
@en
P2093
P2860
P1433
P1476
Bortezomib, melphalan, and pre ...... light chain (AL) amyloidosis.
@en
P2093
Eun-Seok Jeon
Ga Yeon Lee
Hee-Jin Kim
Ji Yun Lee
Jin-Oh Choi
Ju-Hong Min
Jung Eun Lee
Jung-Sun Kim
Kihyun Kim
Seok Jin Kim
P2860
P304
P356
10.3109/13506129.2014.960560
P577
2014-09-24T00:00:00Z